In this groundbreaking episode of The Surrogacy Scoop, we sit down with Noor Siddiqui, CEO of Orchid, a cutting-edge reproductive technology company revolutionizing the future of fertility treatment and genetic testing. Orchid's mission is to give everyone the ability to have a healthy child by measuring and mitigating genetic risk, ensuring the next generation can focus on life rather than managing disease. Through innovative science and accessible technology, Orchid is transforming how intended parents, surrogates, and fertility specialists approach family building.

Noor shares her vision for where reproductive genetics is heading and how emerging technologies will continue to revolutionize family building. She discusses the rapid advancement of genetic sequencing capabilities, the decreasing costs that are making these technologies more accessible, and the ethical frameworks being developed to guide their use. The conversation explores how artificial intelligence and machine learning are being applied to genetic data to identify patterns and predict outcomes with greater accuracy. Noor also addresses the potential for genetic editing technologies and the important conversations society needs to have about their appropriate applications in reproductive medicine. She emphasizes Orchid's commitment to democratizing access to genetic information so that all families, regardless of socioeconomic status, can benefit from these advances.